Hazards of CAPD: Interleukin-1 Production
Evidence has been presented to suggest that the peritoneal macrophage is continuously stimulated during CAPD. Stimulants include pyrogen capable of making the macrophage produce interleukin-1 which in its turn will stimulate prostaglandin and fibroblast formation. Other stimulants exist and remain to be defined. The consequences of this stimulation may well be loss of ultrafiltration followed by sclerosing peritonitis in some cases.
KeywordsPeritoneal Dialysis Peritoneal Macrophage Continuous Ambulatory Peritoneal Dialysis Peritoneal Membrane Filter Group
Unable to display preview. Download preview PDF.
- 1.Nolph KD, Ryan L, Moore H, Legrain M, Mion C, and Oreopoulos DE: Factors affecting ultrafiltration in continuous ambulatory peritoneal dialysis. Peritoneal Dial Bull 4: 14, 1984Google Scholar
- 5.Marshall AJ, Baddeley H, Barritt DW, Davies JD, Lee REJ, Low-Beer TS, and Read AE: Practolol peritonitis: A study of 16 cases and a survey of small bowel functon in patients taking beta adrenergic blockers. QJ Med 46: 145, 1977Google Scholar
- 11.Foegh M, Maddox YT, Winchester J, Rakowski T, Schreiner G, and Ramwell PW: Prostacyclin and thromboxane release from human peritoneal macrophages. In B Samuelsson, Paoletti R, and Ramwell P (Eds), Advances in prostaglandin, thromboxane, and leukotriene research. New York: Raven Press, 1983, p 45Google Scholar